CLINICAL_TRIALS
trial_result
· 2014-11-11
Clinical Trial Update: Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia [Phase 3]
Summary
Phase 3 clinical trial update of an intramuscular depot formulation of aripiprazole used as maintenance treatment in schizophrenia; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2014-11-11